The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
Clinical trial NCT04542837 · COMPLETED
Trial details
- NCT number
- NCT04542837
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2022-02-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.